Tolmar Executive and Leadership Team

Jeff Lederman, the Chief Financial Officer at Tolmar, directs all fiscal planning and capital allocation strategies to support the company's pharmaceutical development pipeline. Overseeing financial reporting, treasury functions, and risk management, the Chief Financial Officer ensures the long-term economic stability of the organization. This leadership role involves managing complex budgetary requirements for manufacturing facilities in Northern Colorado while optimizing resource distribution across North American commercial operations. By maintaining rigorous financial controls, Jeff Lederman directly impacts the ability of the company to invest in innovative urology treatments. Lederman also collaborates with the executive team to evaluate market opportunities and drive sustainable growth. Through precise fiscal oversight, the Chief Financial Officer secures the necessary capital to maintain the competitive edge of the firm within the specialty pharmaceutical sector, ensuring that all operational investments align with the broader corporate mission of delivering high-quality therapeutic solutions to patients.

Shawn Silvestri, the President & Chief Operating Officer at Tolmar, directs the end-to-end manufacturing and product development operations based in Northern Colorado. Overseeing supply chain logistics and facility management, the President & Chief Operating Officer ensures that production standards meet the rigorous demands of the pharmaceutical industry. This leadership role involves coordinating cross-functional teams to streamline the transition from development to commercialization. By optimizing operational efficiency, Shawn Silvestri directly impacts the ability of the company to deliver specialty pharmaceuticals to the market consistently. Silvestri also manages the integration of internal processes to support the broader growth objectives of the firm. Through the implementation of scalable manufacturing strategies, the President & Chief Operating Officer maintains the operational integrity of the organization, ensuring that all production activities support the mission of providing high-quality urology treatments to patients throughout the North American market and beyond.

Steve Griffin, the President (North America) at Tolmar, directs the commercial strategy and market expansion efforts across the United States and Canada. Overseeing the Buffalo Grove commercial headquarters, the President (North America) ensures that sales and distribution networks effectively reach healthcare providers and patients. This leadership role involves managing regional market penetration for the urology portfolio and driving revenue growth through targeted commercial initiatives. By aligning regional operations with the global mission of the company, Steve Griffin directly impacts the market presence of the firm. Griffin also collaborates with other C-suite leaders to refine product positioning and respond to evolving healthcare trends. Through the execution of robust commercial strategies, the President (North America) strengthens the competitive position of the organization, ensuring that the specialty pharmaceutical offerings reach the intended patient populations while maintaining the high standards of service expected within the North American healthcare landscape.

Anjan Chatterjee, the Chief Medical Officer & Chief Marketing Officer at Tolmar, directs clinical development programs and commercial brand strategies for the urology portfolio. Overseeing the integration of medical insights into market positioning, the Chief Medical Officer & Chief Marketing Officer ensures that product messaging remains grounded in scientific evidence. This leadership role involves managing clinical trial data and translating complex therapeutic benefits into actionable commercial campaigns across North America. By aligning medical affairs with marketing objectives, Anjan Chatterjee directly impacts the successful launch and adoption of specialty pharmaceuticals. Chatterjee also coordinates with regulatory bodies to maintain compliance while driving brand awareness among healthcare providers. Through the synthesis of clinical expertise and market analysis, the Chief Medical Officer & Chief Marketing Officer strengthens the reputation of the company as a leader in urology, ensuring that every marketing initiative reflects the commitment of the firm to patient-centric innovation and therapeutic excellence.

Michael Elm, the Chief Legal Officer at Tolmar, directs all corporate governance, intellectual property protection, and regulatory compliance initiatives. Overseeing legal strategy for the development and commercialization of specialty pharmaceuticals, the Chief Legal Officer ensures that the company operates within the complex framework of global healthcare laws. This leadership role involves managing litigation, contract negotiations, and the legal aspects of product manufacturing. By mitigating risk and safeguarding the intellectual property of the firm, Michael Elm directly impacts the long-term viability of the urology product pipeline. Elm also provides counsel to the executive team regarding strategic partnerships and market expansion efforts. Through the application of legal expertise, the Chief Legal Officer maintains the ethical and regulatory standards of the organization, ensuring that all business activities remain aligned with the commitment of the company to innovation and compliance within the highly regulated pharmaceutical industry.